Acciones Beleave Inc. Canadian Securities Exchange
Acciones
BE
CA0775611084
Farmacéuticos
Ventas 2018 | - | Ventas 2019 | 2,37 3,25 2,2 | Capitalización | 30,37 M 41,52 M 28,2 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -12 M -16,4 M -11,14 M | Resultado Neto 2019 | -33 M -45,11 M -30,64 M | VE / Ventas 2018 | - |
Posición de caja neta 2018 | 5,2 M 7,11 M 4,83 M | Deuda neta 2019 | 10,32 M 14,1 M 9,58 M | VE / Ventas 2019 | 17.137.012 x |
P/E ratio 2018 |
-4,72
x | P/E ratio 2019 |
-0,76
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 98,39 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | - | 26/05/00 | |
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/15 |
Kevin Keagan
BRD | Director/Board Member | - | 24/10/18 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/15 |
Founder | - | 26/05/00 | |
Kevin Keagan
BRD | Director/Board Member | - | 24/10/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+40,09 % | 6157,69 M | |
-16,34 % | 4462,61 M | |
-7,11 % | 3268,89 M | |
+5,14 % | 3197,81 M | |
-0,18 % | 2599,21 M | |
+47,93 % | 1975,39 M | |
-7,15 % | 1697,69 M | |
+0,67 % | 1661,22 M | |
-8,73 % | 1609,03 M |